Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 106,011 | 94,181 | 75,410 | 129,122 | 8,140 |
| Depreciation Amortization | 2,237 | 2,171 | -1,485 | 120 | 108 |
| Income taxes - deferred | 14,089 | 16,877 | 14,067 | -76,703 | N/A |
| Accounts receivable | -6,270 | -2,340 | -2,288 | -5,440 | -3,639 |
| Accounts payable and accrued liabilities | 3,161 | -735 | -389 | 6,289 | 965 |
| Other Working Capital | -5,357 | -4,687 | 3,926 | -5,714 | 1,156 |
| Other Operating Activity | 38,099 | 30,650 | 26,424 | 13,261 | 11,661 |
| Operating Cash Flow | $151,970 | $136,117 | $115,665 | $60,935 | $18,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 302,089 | 182,295 | 142,655 | 29,950 | N/A |
| PPE Investments | -1,238 | -1,088 | -298 | -419 | -194 |
| Purchase Of Investment | -420,114 | -299,035 | -233,124 | -102,987 | N/A |
| Investing Cash Flow | $-119,263 | $-117,828 | $-90,767 | $-73,456 | $-194 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -15,134 | -14,779 |
| Common Stock Issued | 23,226 | 8,419 | 9,322 | 7,181 | 7,683 |
| Common Stock Repurchased | -9,945 | -30,975 | -23,657 | 0 | 0 |
| Other Financing Activity | -1,067 | -6,089 | 0 | 0 | 0 |
| Financing Cash Flow | $12,214 | $-28,645 | $-14,335 | $-7,953 | $-7,096 |
| Beginning Cash Position | 31,269 | 41,625 | 31,062 | 51,536 | 40,435 |
| End Cash Position | 76,190 | 31,269 | 41,625 | 31,062 | 51,536 |
| Net Cash Flow | $44,921 | $-10,356 | $10,563 | $-20,474 | $11,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | 151,970 | 136,117 | 115,665 | 60,935 | 18,391 |
| Capital Expenditure | -1,238 | -1,088 | -298 | -419 | -194 |
| Free Cash Flow | 150,732 | 135,029 | 115,367 | 60,516 | 18,197 |